tirzepatide and nash What Is Used for? Approved Potential Uses Tirzepatide Shows Promise in Treating

Ro launched in 2015 and expanded into weight-loss services around 2021

Clinical trial data shows approximately 25-30% of weight lost consists of lean mass (including muscle) without specific interventions

Novo Nordisk and Eli Lilly have told a similar story in the GLP-1 spacefrom Liraglutide to Semaglutide, and from Dulaglutide to Tirzepatide, the next generation of products has exceeded the success of their predecessors, continuing the legacy of diabetes giants

In SURMOUNT-2 (adults with obesity/overweight and type 2 diabetes), tirzepatide achieved up to about 15.7% at 72 weeks

FAQ What are GLP-1 medications, and how do they work

Understanding GLP-1 Agonists Originally developed for diabetes, GLP-1 medications mimic hormones that help regulate appetite and blood sugar